Abcellera Biologics Inc (ABCL)

$5.87 -0.03 (-0.51%)
Market Cap 1.76B
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 6,624,100
Avg Vol 5,232,460
Day's Range N/A - N/A
Shares Out 298.83M
Stochastic %K 72%
Beta 0.69
Analysts Strong Sell
Price Target $9.29

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
AmericanGreeed
AmericanGreeed Oct. 7 at 1:27 AM
$ABCL $BURU $RR full of shit
1 · Reply
BstnGeorge
BstnGeorge Oct. 6 at 11:51 PM
$RR $ABCL $BURU I feel like it’s been to easy lately idk my shit just keeps going up!
3 · Reply
Ed_Ng
Ed_Ng Oct. 6 at 10:14 PM
$ABCL this chart looks like going to zero while market continues hitting ATH
1 · Reply
OnChainAce
OnChainAce Oct. 6 at 5:53 PM
$ABCL When in doubt, zoom out. ABCL is free under $10
0 · Reply
nUme22
nUme22 Oct. 6 at 5:47 PM
$ABCL RSI dropping at around 40... soon this will soar pass 10..
0 · Reply
Amires
Amires Oct. 6 at 3:47 PM
$ABCL I love you too Ed. I just wonder how much money you have left to lose... is the pants still on or that s gone too???!!!
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Oct. 6 at 3:38 PM
$ABCL Not worried at all ABCL is in a growth stage very undervalued, it will burst upwards to 10ish at least just time is all it needs 😀 😀 🙌
0 · Reply
Chebsmcgee
Chebsmcgee Oct. 6 at 3:29 PM
$ABCL up 20%AH and flat tomorrow again boys don’t worry
0 · Reply
Ed_Ng
Ed_Ng Oct. 6 at 3:18 PM
$ABCL up 1% and guy like this comes back like it just hits ATH 😂 lol
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Oct. 6 at 3:11 PM
$ABCL Back in on the dip made my profits in Rlay now back in. Looks good, hows Ed. Lol
0 · Reply
Latest News on ABCL
AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 20 hours ago

AbCellera Biologics: Entering Growth Phase After A Pause

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 29, 2025, 4:05 PM EDT - 7 days ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 26 days ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 27, 2025, 9:00 AM EDT - 5 weeks ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 12, 2025, 4:05 PM EDT - 7 weeks ago

AbCellera to Participate at Upcoming Investor Conferences in September

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:48 PM EDT - 2 months ago

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Aug 7, 2025, 4:05 PM EDT - 2 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 4:05 PM EDT - 3 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 30, 2025, 1:00 PM EDT - 4 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 14, 2025, 5:00 PM EDT - 5 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 12, 2025, 3:30 PM EDT - 5 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 9, 2025, 7:30 PM EDT - 5 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 5 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 5 months ago

AbCellera Reports Q1 2025 Business Results

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 29, 2025, 3:00 PM EDT - 5 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 8, 2025, 4:05 PM EDT - 6 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 4:05 PM EDT - 6 months ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 25, 2025, 4:30 PM EDT - 6 months ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:26 PM EST - 7 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Full Year 2024 Business Results

AbCellera to Participate at Upcoming Investor Conferences in March

Feb 11, 2025, 4:05 PM EST - 8 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 21, 2025, 4:05 PM EST - 9 months ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Jan 13, 2025, 9:00 AM EST - 9 months ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 10 months ago

AbCellera Biologics: Still A Concept Stock

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 21, 2024, 4:05 PM EST - 11 months ago

AbCellera to Present at Upcoming Investor Conferences in December and January

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 7, 2024, 10:05 AM EST - 11 months ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 7:22 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

AbCellera to Present at Upcoming Investor Conferences in September

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 28, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:00 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

May 1, 2024, 9:00 AM EDT - 1 year ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Apr 8, 2024, 12:05 PM EDT - 1 year ago

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 3, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

Mar 19, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

Mar 11, 2024, 9:00 AM EDT - 1 year ago

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

BIIB

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

Mar 5, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

AbCellera Announces Resignation of Board Member

Feb 23, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Resignation of Board Member

AbCellera to Present at Upcoming Investor Conferences in March

Feb 22, 2024, 8:15 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in March

AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 11:45 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript

AmericanGreeed
AmericanGreeed Oct. 7 at 1:27 AM
$ABCL $BURU $RR full of shit
1 · Reply
BstnGeorge
BstnGeorge Oct. 6 at 11:51 PM
$RR $ABCL $BURU I feel like it’s been to easy lately idk my shit just keeps going up!
3 · Reply
Ed_Ng
Ed_Ng Oct. 6 at 10:14 PM
$ABCL this chart looks like going to zero while market continues hitting ATH
1 · Reply
OnChainAce
OnChainAce Oct. 6 at 5:53 PM
$ABCL When in doubt, zoom out. ABCL is free under $10
0 · Reply
nUme22
nUme22 Oct. 6 at 5:47 PM
$ABCL RSI dropping at around 40... soon this will soar pass 10..
0 · Reply
Amires
Amires Oct. 6 at 3:47 PM
$ABCL I love you too Ed. I just wonder how much money you have left to lose... is the pants still on or that s gone too???!!!
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Oct. 6 at 3:38 PM
$ABCL Not worried at all ABCL is in a growth stage very undervalued, it will burst upwards to 10ish at least just time is all it needs 😀 😀 🙌
0 · Reply
Chebsmcgee
Chebsmcgee Oct. 6 at 3:29 PM
$ABCL up 20%AH and flat tomorrow again boys don’t worry
0 · Reply
Ed_Ng
Ed_Ng Oct. 6 at 3:18 PM
$ABCL up 1% and guy like this comes back like it just hits ATH 😂 lol
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Oct. 6 at 3:11 PM
$ABCL Back in on the dip made my profits in Rlay now back in. Looks good, hows Ed. Lol
0 · Reply
Plutten1973
Plutten1973 Oct. 6 at 3:04 PM
$ABCL Not many to borrow for the shorters
1 · Reply
Ed_Ng
Ed_Ng Oct. 6 at 3:00 PM
$ABCL you know this guy will disappear when it drops hard. All time highe and bubble market already. It can burst anytime soon and this POS will drop even harder. Stop dreaming.
1 · Reply
Amires
Amires Oct. 6 at 2:47 PM
$ABCL nothing surprising... just the small retails realizing some profit... support is really holding strong... once they are done and off load to the hand of instituionals and insiders who are long term holders, just like the last leg, we will then head to 7 and 8 territories... I will hold mine tight and ride up this wave... good luck!
1 · Reply
Ed_Ng
Ed_Ng Oct. 6 at 2:42 PM
$ABCL no, just overpriced right now.
1 · Reply
MikeyCook
MikeyCook Oct. 6 at 2:39 PM
$ABCL tight
0 · Reply
skullcool01
skullcool01 Oct. 6 at 2:23 PM
$ABCL any bad news?
0 · Reply
MikeyCook
MikeyCook Oct. 5 at 3:03 PM
$ABCL the 10x is loading...
1 · Reply
RocroBio
RocroBio Oct. 4 at 10:13 PM
$ABCL $CRBU $CRSP $EDIT
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 7:40 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ABCL Current Share Price: $5.90 Contracts: $ABCL January 15, 2027 $7 Calls Scale in: $1.99- $2.43 Scale out: $3.10-$3.98 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
iTrade_Price
iTrade_Price Oct. 4 at 6:43 PM
$ABCL - 6 is the level to break and close above
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 4 at 6:12 PM
$ABCL $C $OUST $NNDM Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
Odoji
Odoji Oct. 4 at 12:06 AM
$ABCL
0 · Reply